alpha lipoic acid,ascorbyl palmitate,Ascorbic acid,Betacarotene,Biotin,calcium citrate tetrahydrate,colecalciferol,Calcium panto - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

prenatal methyl capsules

mthfr support australia pty ltd - alpha lipoic acid,ascorbic acid,ascorbyl palmitate,betacarotene,biotin,calcium citrate tetrahydrate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,d-alpha-tocopheryl acid succinate,hydroxocobalamin,inositol,levomefolate calcium,magnesium citrate,manganese (ii) glycinate,mecobalamin (co-methylcobalamin),nicotinamide,phytomenadione,potassium iodide,pyridoxal 5-phosphate monohydrate,riboflavin sodium phosphate,selenomethionine,sodium molybdate dihydrate,thiamine -

Australia - English - Department of Health (Therapeutic Goods Administration)

mthfrgroup multivitamin

Australia - English - Department of Health (Therapeutic Goods Administration)

pantoprazole myl pantoprazole (as sodium sesquihydrate) 40 mg enteric-coated tablet blister pack.

alphapharm pty ltd - pantoprazole sodium sesquihydrate, quantity: 45.12 mg (equivalent: pantoprazole, qty 40 mg) - tablet, enteric coated - excipient ingredients: crospovidone; sodium hydroxide; mannitol; macrogol 6000; hypromellose; sodium starch glycollate; colloidal anhydrous silica; sodium carbonate; calcium stearate; titanium dioxide; purified talc; iron oxide yellow; xanthan gum; polyvinyl alcohol; lecithin; purified water; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate - 1. symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion:,i) duodenal ulcer ii) gastric ulcer iii) gastro-oesophageal reflux disease (gord): - symptomatic gord. the treatment of heartburn and other symptoms associated with gord - reflux oesophagitis iv) gastrointestinal lesions refractory h2 blockers v) zollinger-ellison syndrome,patients whose gastric or duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis.,3. for eradication of helicobacter pylori, treatment with pantoprazole and one of the following combinations of antibiotics:,i) clarithromycin and amoxicillin or ii) clarithromycin and metronidazole or iii) amoxicillin and metronidazole,is recommended in cases

Australia - English - Department of Health (Therapeutic Goods Administration)

pantoprazole myl pantoprazole (as sodium sesquihydrate) 20 mg enteric-coated tablet blister pack.

alphapharm pty ltd - pantoprazole sodium sesquihydrate, quantity: 22.56 mg (equivalent: pantoprazole, qty 20 mg) - tablet, enteric coated - excipient ingredients: mannitol; crospovidone; hypromellose; macrogol 6000; sodium carbonate; sodium starch glycollate; colloidal anhydrous silica; sodium hydroxide; calcium stearate; titanium dioxide; purified talc; iron oxide yellow; xanthan gum; polyvinyl alcohol; lecithin; purified water; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate - 1. symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion:,i) duodenal ulcer ii) gastric ulcer iii) gastro-oesophageal reflux disease (gord): - symptomatic gord. the treatment of heartburn and other symptoms associated with gord - reflux oesophagitis iv) gastrointestinal lesions refractory h2 blockers v) zollinger-ellison syndrome,patients whose gastric or duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis.,3. for eradication of helicobacter pylori, treatment with pantoprazole and one of the following combinations of antibiotics:,i) clarithromycin and amoxicillin or ii) clarithromycin and metronidazole or iii) amoxicillin and metronidazole,is recommended in cases

Australia - English - Department of Health (Therapeutic Goods Administration)

pantoprazole mylan pantoprazole 20mg (as sodium sesquihydrate) tablet blister pack

alphapharm pty ltd - pantoprazole sodium sesquihydrate, quantity: 22.55 mg (equivalent: pantoprazole, qty 20 mg) - tablet, enteric coated - excipient ingredients: lactose monohydrate; magnesium stearate; purified talc; microcrystalline cellulose; triethyl citrate; croscarmellose sodium; colloidal anhydrous silica; purified water; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate; titanium dioxide; iron oxide yellow; quinoline yellow aluminium lake; polyvinyl alcohol; macrogol 3350 - 1. symptomatic improvement and healing of the following gastrointestinal diseases which require a reduction in acid secretion: duodenal ulcer; gastric ulcer; gastroesophageal reflux disease (gord): - symptomatic gord.the treatment of heartburn and other symptoms associated with gord; - reflux oesophagitis; gastrointestinal lesions refractory to h2-blockers; zollinger-ellison syndrome; patients whose gastric or duodenal ulceration is not associated with ingestion of nsaids require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. 2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. 3. prevention of gastroduodenal lesions and dyspeptic symptoms associated with nonselective nsaids in increased risk patients with a need for continuous nonselective nsaid treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pantoprazole mylan pantoprazole 20mg (as sodium sesquihydrate) tablet bottle

alphapharm pty ltd - pantoprazole sodium sesquihydrate, quantity: 22.55 mg (equivalent: pantoprazole, qty 20 mg) - tablet, enteric coated - excipient ingredients: triethyl citrate; microcrystalline cellulose; magnesium stearate; lactose monohydrate; purified talc; colloidal anhydrous silica; croscarmellose sodium; purified water; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate; titanium dioxide; iron oxide yellow; quinoline yellow aluminium lake; polyvinyl alcohol; macrogol 3350 - 1. symptomatic improvement and healing of the following gastrointestinal diseases which require a reduction in acid secretion: duodenal ulcer; gastric ulcer; gastroesophageal reflux disease (gord): - symptomatic gord.the treatment of heartburn and other symptoms associated with gord; - reflux oesophagitis; gastrointestinal lesions refractory to h2-blockers; zollinger-ellison syndrome; patients whose gastric or duodenal ulceration is not associated with ingestion of nsaids require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. 2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. 3. prevention of gastroduodenal lesions and dyspeptic symptoms associated with nonselective nsaids in increased risk patients with a need for continuous nonselective nsaid treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pantoprazole mylan pantoprazole 40mg (as sodium sesquihydrate) tablet bottle

alphapharm pty ltd - pantoprazole sodium sesquihydrate, quantity: 45.1 mg (equivalent: pantoprazole, qty 40 mg) - tablet, enteric coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; triethyl citrate; microcrystalline cellulose; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350; purified water; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate - 1. symptomatic improvement and healing of the following gastrointestinal diseases which require a reduction in acid secretion: duodenal ulcer; gastric ulcer; gastroesophageal reflux disease (gord): - symptomatic gord.the treatment of heartburn and other symptoms associated with gord; - reflux oesophagitis; gastrointestinal lesions refractory to h2-blockers; zollinger-ellison syndrome; patients whose gastric or duodenal ulceration is not associated with ingestion of nsaids require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. 2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. 3. prevention of gastroduodenal lesions and dyspeptic symptoms associated with nonselective nsaids in increased risk patients with a need for continuous nonselective nsaid treatment.

Israel - English - Ministry of Health

calcium - d - source

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - tablets effervescent - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Australia - English - Department of Health (Therapeutic Goods Administration)

salpraz heartburn relief pantoprazole (as sodium sesquihydrate) 20 mg enteric-coated tablet blister pack (reformulation 2)

alphapharm pty ltd - pantoprazole sodium sesquihydrate, quantity: 22.56 mg - tablet, enteric coated - excipient ingredients: carnauba wax; triethyl citrate; calcium stearate; mannitol; purified water; sodium carbonate; povidone; macrogol 6000; purified talc; crospovidone; hypromellose; methacrylic acid - ethyl acrylate copolymer (1:1); titanium dioxide; iron oxide yellow; xanthan gum; polyvinyl alcohol; lecithin - symptomatic relief of heartburn, acid regurgitation and other symptoms associated with gastroesophageal reflux disease (gord).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

alpha-scud elite insecticide